MedTrace Logo

The Rate and Predictors of Vaginal Bleeding Among Women With Placenta Previa

NCT05645848 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2022-12-12

No results posted yet for this study

Summary

Placenta previa is usually diagnosed when the placenta implanted in the lower uterine segment, thus partially or totally overlying the internal os . It occurs with an incidence of 0.3-0.5%. It is associated mainly with prior caesarean delivery . The condition is frequently complicated by invasion of placental villi beyond the decidua basalis causing placenta accreta . Placenta previa is a major cause of massive haemorrhage during pregnancy and after delivery . The antepartum bleeding from placenta previa- can be life-threatening, thus, the prediction of this bleeding is of great importance . It is important to distinguish between women at high and low risk for antepartum haemorrhage with placenta previa especially at late pregnancy . However, the potential risk factors for antepartum haemorrhage in women with placenta previa have not been thoroughly examined.

Conditions

  • Placenta Previa
  • Vaginal Bleeding
  • Antepartum Hemorrhage

Interventions

DEVICE

Ultrasonography

Abdominal ultrasound in pregnant women with placenta previa

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Kamal M Zahran, professor · department of obstetrics and gynecology, faculty of medicine, Assuit University, Egypt

  • Mohamed K Ali, doctor · department of obstetrics and gynecology, faculty of medicine, Assuit University, Egypt

  • Mohamed M Abd-allah, doctor · department of obstetrics and gynecology, faculty of medicine, Assuit University, Egypt

  • Ismael O Ali, resident · department of obstetrics and gynecology, faculty of medicine, Assuit University, Egypt

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-31
Primary Completion
2024-12-31
Completion
2025-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05645848 on ClinicalTrials.gov